EbolaMap Global Outbreak Tracker
Cet article est disponible uniquement en anglais.
Blog
UPDATE 8 min read

DRC Ebola Snapshot, 3 October 2026: How to Read 8,544 Cases and 4,114 Deaths

WHO's daily table records 8,544 confirmed cases and 4,114 deaths in DRC. This data note explains the CFR, recoveries, reporting lag and how international treatment cases are counted.

By ·
Also available: EN

The Latest WHO Table

The WHO daily epidemiological update records 8,544 confirmed Bundibugyo virus disease cases, 4,114 confirmed deaths, and 2,230 recoveries in the Democratic Republic of the Congo as of 3 October 2026.

The same table retains 20 confirmed cases and two deaths in Uganda and one recovered imported case in France. Before the later Kenya notification, the confirmed multicountry total was therefore 8,565 cases and 4,116 deaths.

CountryData date shown by WHOConfirmed casesConfirmed deathsRecoveries
DRC3 October 20268,5444,1142,230
Uganda21 July 202620218
France6 July 2026101
TotalMixed country dates8,5654,1162,249

Update boundary: Kenya reported its first imported case on 6 October. It is intentionally not included in this 3 October snapshot and is covered in a separate EbolaMap article.


The Crude CFR Is About 48.1%

Dividing 4,114 reported deaths by 8,544 confirmed cases gives a crude case-fatality ratio of approximately 48.1% for the DRC.

That calculation is useful, but it is not a final biological fatality rate. Active patients have not yet reached an outcome, deaths may be reported later than cases, and records can be revised. The 2,230 recoveries should not be used with deaths to calculate a separate “resolved-case CFR” without understanding which outcomes are complete and whether the reporting systems use the same cut-off.

The crude CFR is best treated as a surveillance indicator: persistently high mortality suggests delays in detection and access to care, severe pressure on treatment services, or continued reporting of deaths from communities outside formal treatment pathways.


The Increase Since 29 September Is a Reporting Increase

ECDC reported 8,224 confirmed cases and 3,982 deaths using DRC data through 29 September. Compared with WHO’s 3 October table, the difference is 320 cases and 132 deaths.

Those differences should not be described as 320 people infected and 132 people dying during exactly four calendar days. A national line list is updated when information reaches and passes through the reporting system. New totals can include delayed laboratory results, backlogged records, duplicate removal, and reclassification following investigation.

This distinction is particularly important in remote or insecure areas, where sample transport and reporting may take longer than the disease process itself.


Why the Netherlands and Germany Do Not Add Three More Cases

WHO notes that the DRC count includes one patient receiving treatment in the Netherlands and two patients who received treatment in Germany. All three were initially confirmed in the DRC.

Their treatment destination does not change the country attribution of the infection. Adding them again under the receiving countries would inflate the global total. By contrast, France’s June case was diagnosed and officially reported as an imported French case, so it appears separately.

The rule is straightforward: follow the official surveillance attribution, then describe medical evacuation separately. This is the same method used in EbolaMap’s country table and map.


Confirmed and Probable Counts Should Not Be Mixed Silently

WHO’s table also lists one probable case and one probable death in Uganda. The headline total of 8,565 is a confirmed-case total and does not add that probable case.

Both categories matter, but combining them without a label makes comparisons unreliable. A site that reports confirmed-only today and confirmed-plus-probable tomorrow can create a false increase even if no new event occurred.

EbolaMap therefore states the case definition when different official products use different scopes. See our explainer on suspected, probable and confirmed Ebola classifications for the practical differences.


Geographic Spread Remains the Larger Signal

The latest complete WHO Disease Outbreak News report before this snapshot placed transmission across 63 health zones in seven DRC provinces. Ituri remained the largest focus, while North Kivu had experienced a substantial rise in September. Sud Ubangi had recently become the seventh affected province.

National totals are necessary for measuring scale, but geographic indicators guide operations. A lower national daily increase can coexist with a dangerous new cluster near a border. Conversely, a high daily increase may reflect several established zones reporting delayed results at once.

Useful next indicators include the number of zones reporting cases in the previous 21 days, community deaths, contact follow-up, alert-investigation speed, treatment occupancy, and the time from symptom onset to isolation.


A Reproducible Reading Checklist

When a new Ebola total appears, ask:

  1. What is the data date, not only the publication date?
  2. Are the figures confirmed-only or do they include probable and suspected cases?
  3. Which countries are included?
  4. Are medically evacuated patients attributed to the place of diagnosis or treatment?
  5. Is the increase based on report date, symptom-onset date, or laboratory-confirmation date?
  6. Does the source warn that records remain under review?

This checklist prevents most apparent contradictions between WHO, ECDC, national ministries, and media reports. EbolaMap applies it when updating the live outbreak statistics and maintains source links in the news archive.


Published 3 October 2026. Primary source: WHO daily epidemiological update. DRC figures are updated from national situation reports and may be retrospectively revised.

Sources & editorial review

Page updated October 3, 2026

Editorial verification: claims are checked against the cited public sources by the EbolaMap Editorial Team. This is not licensed-clinician review and the article is not medical advice. See our Editorial Policy and Corrections Policy.

Advertisement